A Case of Trastuzumab-Associated Cardiomyopathy Presenting as an Acute Coronary Syndrome: Acute Trastuzumab Cardiotoxicity
Trastuzumab is a monoclonal antibody highly effective in the treatment of several cancers, but its use is associated with cardiac toxicity which usually responds to cessation of the drug and/or medical therapy. We present an unusual case of acute cardiac toxicity temporally related to administration...
Saved in:
Main Authors: | Sylvana Hidalgo, Carol A. Albright, Gretchen L. Wells |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Case Reports in Cardiology |
Online Access: | http://dx.doi.org/10.1155/2013/473979 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognosis and cardiotoxicity associated to adjuvant trastuzumab for breast cancer: real world study in a public health system
by: Ana Elisa Ribeiro da Silva Cabello, et al.
Published: (2025-01-01) -
Diffuse Spontaneous Laryngeal Hemorrhage with Trastuzumab
by: Lauren Klute, et al.
Published: (2020-01-01) -
Trastuzumab Resistance: Role for Notch Signaling
by: Kinnari Mehta, et al.
Published: (2009-01-01) -
Acute Coronary Syndrome Mimicking Takotsubo Cardiomyopathy or Takotsubo Cardiomyopathy Mimicking Acute Coronary Syndrome?
by: Martin Chaumont, et al.
Published: (2020-01-01) -
Monitoring and management of adverse effects associated with trastuzumab deruxtecan: a UAE-specific consensus
by: Emad Dawoud, et al.
Published: (2025-01-01)